Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.
<h4>Background</h4>Serum lens culinaris agglutinin-reactive fraction of α-fetoprotein (AFP-L3%) has been widely used for HCC diagnosis and follow-up surveillance as tumor serologic marker. However, the prognostic value of high pre-treatment serum AFP-L3% in patients with hepatocellular c...
Saved in:
| Main Authors: | Jiwen Cheng, Wanli Wang, Yingjun Zhang, Xi Liu, Muxing Li, Zheng Wu, Zhengwen Liu, Yi Lv, Bo Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0087011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of PDZD11 in hepatocellular carcinoma: prognostic value and diagnostic potential in combination with AFP
by: Yiyun Ni, et al.
Published: (2025-03-01) -
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients
by: Shujing Huang, et al.
Published: (2017-05-01) -
Androgen receptor promotes arachidonic acid metabolism and angiogenic microenvironment in AFP-negative hepatocellular carcinoma
by: Zhilong Lin, et al.
Published: (2025-07-01) -
Updating AFP Level in Chronic Hepatitis B to Evaluate the Risk of Hepatocellular Carcinoma Occurrence
by: Juferdy Kurniawan, et al.
Published: (2024-10-01) -
Hepatocellular Carcinoma in South Indian Population: Clinical Profile and AFP Correlation with Radiological Tumor Size
by: Sahil Ahmad, et al.
Published: (2025-06-01)